14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PETX
Delisted

Aratana Therapeutics Stock Price (Quote)

$4.92
+0 (+0%)
At Close: Sep 20, 2019

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 20th Sep 2019 PETX stock ended at $4.92. During the day the stock fluctuated 0% from a day low at $4.92 to a day high of $4.92.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Aratana Therapeutics prices

Date Open High Low Close Volume
Feb 22, 2017 $6.52 $6.55 $6.42 $6.50 318 147
Feb 21, 2017 $6.57 $6.60 $6.31 $6.53 657 314
Feb 17, 2017 $6.43 $6.52 $6.27 $6.34 398 426
Feb 16, 2017 $6.49 $6.53 $6.27 $6.45 407 355
Feb 15, 2017 $6.55 $6.55 $6.36 $6.50 546 576
Feb 14, 2017 $6.40 $6.56 $6.27 $6.54 481 791
Feb 13, 2017 $6.65 $6.72 $6.27 $6.36 736 461
Feb 10, 2017 $6.26 $6.74 $6.25 $6.60 984 383
Feb 09, 2017 $6.35 $6.47 $6.16 $6.27 656 112
Feb 08, 2017 $6.15 $6.43 $6.04 $6.33 1 232 452
Feb 07, 2017 $6.58 $6.59 $6.06 $6.14 2 054 247
Feb 06, 2017 $7.23 $7.24 $6.34 $6.59 3 625 657
Feb 03, 2017 $7.98 $8.04 $7.85 $8.03 219 020
Feb 02, 2017 $8.00 $8.04 $7.85 $7.90 227 783
Feb 01, 2017 $8.06 $8.08 $7.89 $8.00 321 525
Jan 31, 2017 $7.55 $8.03 $7.41 $7.99 351 464
Jan 30, 2017 $7.80 $7.81 $7.56 $7.57 213 540
Jan 27, 2017 $7.86 $7.96 $7.63 $7.88 216 691
Jan 26, 2017 $7.91 $8.08 $7.74 $7.82 215 175
Jan 25, 2017 $7.86 $8.12 $7.71 $7.92 467 756
Jan 24, 2017 $7.63 $7.67 $7.35 $7.61 223 654
Jan 23, 2017 $7.62 $7.74 $7.51 $7.61 116 013
Jan 20, 2017 $7.50 $7.76 $7.50 $7.62 153 969
Jan 19, 2017 $7.77 $7.83 $7.44 $7.54 294 636
Jan 18, 2017 $7.75 $7.80 $7.62 $7.79 234 576
Click to get the best stock tips daily for free!

About Aratana Therapeutics

Aratana Therapeutics Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. Its product portfolio includes various therapeutic candidates consisting of small molecule pharmaceuticals and large molecule biologics that target various opportunities in serious medical conditions in pets. The company develops AT-001, a prostag... PETX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT